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Regulation of body temperature critically depends
on thyroid hormone (TH). Recent studies revealed
that TH induces browning of white adipose tissue,
possibly contributing to the observed hyperthermia
in hyperthyroid patients and potentially providing
metabolic benefits. Here, we show that browning
by TH requires TH-receptor b and occurs indepen-
dently of the sympathetic nervous system. The beige
fat, however, lacks sufficient adrenergic stimulation
and is not metabolically activated despite high levels
of uncoupling protein 1 (UCP1). Studies at different
environmental temperatures reveal that TH instead
causes hyperthermia by actions in skeletal muscle
combined with a central body temperature set-point
elevation. Consequently, the metabolic and thermo-
genic effects of systemic hyperthyroidism were
maintained in UCP1 knockout mice, demonstrating
that neither beige nor brown fat contributes to the
TH-induced hyperthermia and elevated glucose
consumption, and underlining that the mere pres-
ence of UCP1 is insufficient to draw conclusions on
the therapeutic potential of browning agents.
INTRODUCTION
Obligatory thermogenesis is defined as heat resulting from
maintenance of vital functions. In homeothermic species living
in thermoneutral conditions, this type of thermogenesis is suffi-
cient to maintain body temperature. Whenever the ambientCell
This is an open access article under the CC BY-Ntemperature is reduced, heat-saving mechanisms, such as
vasoconstriction, decreased movement, and piloerection,
are activated, and adaptive (or facultative) thermogenesis is
induced. Among these adaptive thermogenic mechanisms is
the activation of non-shivering thermogenesis in brown adipose
tissue (BAT). BAT thermogenesis relies on the expression of
uncoupling protein 1 (UCP1) that dissociatesmitochondrial sub-
strate oxidation from ATP synthesis by introducing a proton
leak, resulting in heat release (Cannon and Nedergaard, 2004).
BAT is activated by the sympathetic nervous system (SNS)
releasing norepinephrine (NE) that binds to b3-adrenergic re-
ceptors (ADRB3) on brown adipocytes, leading to an increase
in intracellular cyclic AMP (cAMP) (Zhao et al., 1994). This rise
in cAMP activates, for instance, the conversion of the thyroid
hormone thyroxine (T4) to the more biologically active form
3,30,5-triiodothyronine (T3) by the enzyme deiodinase type 2
(DIO2) (Silva and Larsen, 1983). T3 in turn increases Ucp1
expression (Rabelo et al., 1996). BAT thermogenesis has been
shown to have numerous metabolic benefits, like increased
glucose and lipid uptake (Bartelt et al., 2011; Berbe´e et al.,
2015; Greco-Perotto et al., 1987; Shibata et al., 1989; Heine
et al., 2018), anti-diabetic effects, and amelioration of obesity
(Bartelt et al., 2018; Kajimura et al., 2015; Svensson et al.,
2016). Additionally, it was found that sustained cold exposure
or certain compounds can induce brown adipocyte-like (brite
or beige) cells in subcutaneous white adipose tissue of mice,
a process called browning (Bartelt and Heeren, 2014; Ishibashi
and Seale, 2010; Petrovic et al., 2010; Young et al., 1984). It is
currently assumed that this beige fat might contribute to ther-
mogenesis and may have beneficial metabolic effects, although
the majority of studies have failed to demonstrate whether
increased UCP1 in beige fat also results in higher thermogene-
sis or metabolism on the systemic level (Bartelt and Heeren,Reports 27, 3385–3400, June 11, 2019 ª 2019 The Author(s). 3385
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2014; Harms and Seale, 2013; Kajimura et al., 2015; Keipert and
Jastroch, 2014; Warner and Mittag, 2016).
Thyroid hormones are essential in the regulation of metabolic
and thermoregulatory pathways in mammals (Mullur et al., 2014;
Silva, 2006; Yen, 2001). This becomes evident in hyperthyroid
patients, which show impaired heat tolerance and increased
body temperature (Silva, 2003). The effects of thyroid hormone
on thermogenesis have been studied for decades, establishing
the paradigm that the hormone increases obligatory thermogen-
esis in several tissues, including muscle, which leads to a higher
body temperature (Silva, 2006). Thyroid hormones exert their ac-
tions by the nuclear thyroid hormone receptors (TRs) alpha1
(TRa1), beta1 (TRb1), or beta 2 (TRb2), altering gene expression
(Sap et al., 1986; Tata, 1986; Thompson et al., 1987). TRs are
expressed in almost every tissue and often have overlapping
functions; however, there are tissues that predominantly rely
on TRa1 or TRb, respectively (Yen, 2001). With regard to thermo-
genesis, TRb has been shown to play a role in the regulation of
adaptive thermogenesis by regulating Ucp1 mRNA expression,
and TRa1 seems to modulate adrenergic sensitivity (Ribeiro
et al., 2001; Weiss et al., 1998). However, mice devoid of all
TRs still display competent BAT recruitment and Ucp1 gene
expression but depressed thermogenesis, suggesting a com-
plex interplay between thyroid hormone and body temperature
regulation (Golozoubova et al., 2004). Moreover, it was recently
discovered that TRa1 also controls tail heat loss with secondary
effects for BAT thermogenesis (Warner et al., 2013). Therefore,
thyroid hormones are relevant for almost all aspects of thermo-
regulation, including thermal conductance as well as obligatory
and facultative thermogenesis. In addition to the peripheral
actions, recent studies revealed that thyroid hormone also in-
duces facultative thermogenesis through central mechanisms,
as central hyperthyroidism leads to direct activation of BAT in
an AMP-activated protein kinase (AMPK)-dependent manner in
rats (Alvarez-Crespo et al., 2016; Lo´pez et al., 2010; Martı´nez-
Sa´nchez et al., 2017b) and induces browning in mice (Martı´-
nez-Sa´nchez et al., 2017a). Most interestingly, a recent study
revealed that the TRb agonist GC-1 directly triggers browning
(Lin et al., 2015), an effect that has been reported for thyroid hor-
mone as well (Hoefig et al., 2016; Weiner et al., 2016). The data
suggested that the beige fat recruitment could contribute toFigure 1. Hyperthyroidism Improves Glucose Tolerance and Induces B
(A) Scheme of treatment regimen for induction of hyperthyroidism in mice.
(B) Serum total T4 levels after 14 days of treatment.
(C) Serum total T3 levels after 14 days of treatment.
(D) ipGTT after 12 days of treatment with THs.
(E) Area under curve (AUC) of ipGTT (D).
(F) Rectal temperature of control and T3- and T4-treated mice over 14 days of tr
(G) Rectal temperature at the end of treatment.
(H) iBAT temperature as measured by infrared thermography over 14 days of tre
(I) iBAT temperature as measured by infrared thermography at the end of treatm
(J) Tail temperature of control and T3- and T4-treated mice as measured by infra
(K) Hepatic PK activity in control and T3- and T4-treated mice.
(L) Hepatic PEPCK activity in control and T3- and T4-treated mice.
(M) Hepatic glycogen content of control and T3- and T4-treated mice.
(N) Representative H&E stainings of iBAT and ingWAT of control and T3- and T4
(O and P) Gene expression analysis in (O) ingWAT and (P) iBAT in control and T3
(Q) Direct comparison of ingWAT UCP1 protein expression of T3-treated mice to
Data are presented as mean ± SEM; n = 6–8. *p < 0.05; **p < 0.01; ***p < 0.001.the body temperature increase observed in hyperthyroidism
and might provide favorable metabolic effects. The findings
therefore challenge the well-established model that thyroid hor-
mone only modulates basal metabolic rate and obligatory ther-
mogenesis (Silva, 2006) and indicate that beige fat might be a
prominent player in the thermogenic and metabolic effects of
the hormone. Therefore, we aimed to test the role of thermogenic
adipose tissue in body temperature regulation and for the meta-
bolic benefits observed in systemic hyperthyroidism.
RESULTS
Hyperthyroidism Improves Glucose Tolerance and
Induces Browning of Inguinal White Adipose Tissue
To establish the effects of hyperthyroidism, wild-type (WT) mice
were treated for 14 days with either 0.5 mg/L T3 or 1 mg/L T4 in
drinking water (Figure 1A). Treatment with T3 induced a substan-
tial hyperthyroidism with an 8.5-fold increase in serum total T3
(tT3) and a 90% decrease in serum tT4 (Figures 1B and 1C).
Hyperthyroidism was fully achieved after 24 h (not shown),
persistently observed over the course of a day (Figures S1A
and S1B), and leads to a complete suppression of pituitary thy-
roid-stimulating hormone (TSH) (Figure S1C). It was accompa-
nied by an increase in energy expenditure, a lower respiratory
quotient, and an increase in body weight and length as expected
(Neilsen, 1953; Rakov et al., 2016; Green, 1975), as well as
hyperphagia (Figures S1D–S1H). Our model for T4-induced
hyperthyroidism was milder, with no significant elevation in tT3
and a 7.4-fold increase in serum tT4 (Figures 1B and 1C) but
no significant changes in bodyweight, length, or food intake (Fig-
ures S1F–S1H). As hyperthyroidism is associated with improved
glucose tolerance, we performed an intraperitoneal glucose
tolerance test (ipGTT) and found reduced blood glucose levels
in T3-treated, but not T4-treated, mice (Figures 1D and 1E; p <
0.01 for T3; p = 0.34 for T4; repeated measures [RM]-ANOVA).
Core body temperature in thyroid-hormone-treated mice started
to increase after 1 week of treatment (Figure 1F) and was signif-
icantly elevated in T3-treated, but not T4-treated, mice after
2 weeks (T3 p < 0.01; T4 p = 0.09; Figure 1G). Skin temperature
above the interscapular brown adipose tissue (iBAT) as
measured by infrared thermography did not significantly changerowning of ingWAT
eatment.
atment.
ent normalized to rectal temperature.
red thermography over 14 days of treatment.
-treated mice. Scale bar 10 mm.
- and T4-treated mice.
control iBAT.
See also Figure S1.
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over the course of the 14 days of treatment (Figures 1H and S1I)
but was significantly decreased upon T3 at the end of the treat-
ment, in absolute values but also when normalized to body
temperature (Figures 1H and 1I). In parallel, skin temperature
above the inguinal white adipose tissue (ingWAT) was un-
changed (Figure S1J). Interestingly, tail temperature was signifi-
cantly elevated over the course of the T3 treatment indicative of
vasodilation to dissipate excess heat starting at day 4 of the
treatment (Figure 1J). To further investigate glucosemetabolism,
we measured the activities of rate-limiting steps in glycolysis
(pyruvate kinase [PK]) and gluconeogenesis (phosphoenolpyr-
uvate-carboxykinase [PEPCK]) in liver. PK activity was signifi-
cantly decreased in T3- and T4-treated mice (Figure 1K), and
PEPCK activity was increased in T3-treated mice (Figure 1L).
Hepatic glycogen content was decreased in T3-treated mice
(Figure 1M), indicating a higher systemic need for glucose. Organ
weights determined at the time of sacrifice showed the expected
cardiac hypertrophy in T3-treated, but not T4-treated, mice (Fig-
ures S1K and S1L). In both T3- and T4-treated animals, iBAT de-
pots were significantly larger and appeared paler, suggesting
higher lipid deposition (Figure S1M), which was confirmed by
H&E staining (Figure 1N). Interestingly, when we investigated in-
gWAT morphology (Figure 1N), an increase in smaller, multilocu-
lar fat cells was observed, indicating induction of browning by
thyroid hormone, as reported previously (Alvarez-Crespo et al.,
2016; Finan et al., 2016; Weiner et al., 2016). To test this on
the molecular level, we measured gene expression of thermo-
genic marker genes (uncoupling protein 1 [Ucp1]; deiodinase 2
[Dio2]; peroxisome proliferator-activated receptor gamma coac-
tivator 1 alpha [Ppargc1a]; mitochondrial transcription factor A
[Tfam]; PR domain containing 16 [Prdm16]; cell-death-inducing
DFFA-like effector a [Cidea]; b3-adrenergic receptor [Adrb3];
Figures 1O and 1P) and UCP1 protein expression (Figure 1Q).
In ingWAT, we found an elevation of several thermogenic
markers, including Ucp1, Dio2, Ppargc1a, and Cidea in T3-
and T4-treated animals, and Adrb3 mRNA was reduced upon
T3 treatment (Figure 1O). In contrast, iBAT gene expression anal-
ysis showed a decrease in most thermogenic and brown fat
marker genes (Figure 1P). Interestingly, despite reduced mRNA
levels, UCP1 protein was elevated in T3-treated iBAT with no
change in the protein level of the mitochondrial respiratory chain
complexes (Figures S1N–S1P). In T3-treated ingWAT, UCP1
protein reached levels comparable to about one-third of the
amount found in untreated iBAT (Figure 1Q), suggesting a
possibly high thermogenic potential. Browning was also induced
by T3 and T4 in gonadal WAT (gWAT) on the mRNA level (Fig-
ure S1Q); however, no significant amount of UCP1 protein was
detectable in this tissue (Figure S1R). Given that the T3 treatment
entirely suppressed TSH, thus potentially blocking the oscillating
rhythm of thyroid hormone secretion, we tested whether the lack
of a circadian rhythm would by itself cause browning. Using
clock-deficient Per1/Per2 double mutant (double knockout
[DKO]) mice, we confirmed that this was not the case, as Ucp1
mRNA expression was not induced in ingWAT (Figure S1S).
Taken together, these data show that T3 and T4 are capable
of browning ingWAT on the molecular level; however, the sys-
temic effects of hyperthyroidism are more pronounced in the
T3-treated group.3388 Cell Reports 27, 3385–3400, June 11, 2019Ucp1 Expression in ingWAT Is Dependent on TRb
As it was reported that browning of ingWAT can be induced by
TRb-selective compounds (Lin et al., 2015), we investigated the
metabolic phenotype of global TRb knockout (KO) mice (Fig-
ure 2A). These mice showed elevated serum tT3 and tT4 levels
(Figures S2A and S2B) due to the impaired feedback of the hypo-
thalamus-pituitary-thyroid axis (Forrest et al., 1996). Although
ipGTT was not altered in TRb KO mice compared to their WT
littermates (Figures 2B and 2C; p = 0.41 for TRb; RM-ANOVA),
their basal metabolic rate (BMR) (defined here as metabolism at
thermoneutrality) was significantly increased (Figures 2D and
2E). This did, however, not translate to an increase in daily energy
expenditure at room temperature (Figures S2C and S2D), sug-
gesting a compensatory adaptation of non-shivering thermogen-
esis. Despite being hyperthyroid, TRb KO mice did not have
elevated body or iBAT temperature (Figures 2F–2H), and the his-
tology of iBAT and ingWAT was similar to controls (Figure 2I).
When investigating gene expression in ingWAT, we found that
Dio2 and Adrb3 expression were not altered in hyperthyroid
TRb KO mice, but Ucp1 mRNA expression was even lower than
in controls (Figure 2J). In iBAT, Ucp1 expression was not altered
onmRNA (Figure 2K) or protein level (FiguresS2E andS2F). These
data demonstrate that browning of ingWAT by thyroid hormone
on the molecular level depends on intact TRb signaling.
Hyperthyroidism Decreases Adipose Tissue Glucose
and Lipid Uptake
Activation of thermogenesis in adipose tissues is associated with
increased glucose uptake (Cannon and Nedergaard, 2004). To
test this directly, we performed [18]fluoro-2-deoxyglucose–
positron emission tomography (18FDG-PET)/computed tomogra-
phy (CT) scans of T3- and T4-treated mice. Despite elevated
UCP1 levels, ingWAT glucose uptake was not increased but
decreased upon systemic T3 or T4 treatment (Figures 3A and
3B). Likewise, glucose uptake in iBAT was reduced (Figures 3C
and 3D), and no change was observed in gWAT or soleus muscle
(Figures S2G and S2H). 18FDG-PET/CT may, however, not accu-
rately reflect brown or beige fat thermogenic activity (Hankir et al.,
2017; Olsen et al., 2017), as thermogenesis is mainly fueled
by fatty acids (Bartelt et al., 2011; Cannon and Nedergaard,
2004). We therefore also measured uptake of triglyceride-rich
lipoproteins (TRLs) in hyperthyroid mice. In iBAT, TRL uptake
significantly decreased to about one-third in systemically T3-
and T4-treated mice, and no difference was observed in ingWAT
(Figure 3E). Given the lack of metabolic activation in the presence
of elevatedUCP1protein levels, wehypothesized that the thermo-
genic capacity of the tissue might not be fully exploited due
to insufficient adrenergic stimulation. Therefore, we injected
mice with 1 mg/kg NE to stimulate maximum non-shivering
thermogenesis. Control and T3-treated animals showed an
elevation in oxygen consumption after NE injection (Figure 3F);
however, the response was more pronounced in T3-treated
mice, indicating a higher thermogenic capacity. Our hypothesis
of insufficient adrenergic stimulation was further supported on
themolecular level, aswe found no significant elevation in ingWAT
and iBAT of intracellular cAMP (Figures 3G and 3H), phospho-
hormone sensitive lipase (HSL; Figures 3I and 3J), or free fatty
acids (Figures 3K and 3L), which are required for activation of
Figure 2. Ucp1 Expression in ingWAT Is Dependent on TRb Expression
(A) Adult TRb KO mice and their WT littermates were metabolically characterized.
(B) ipGTT of WT and TRb KO mice.
(C) Area under curve of ipGTT (B).
(D) BMR of WT and TRb KO mice normalized to body weight.
(E) BMR of WT and TRb KO mice plotted against body weight.
(F) Rectal temperature of WT and TRb KO mice.
(G) iBAT temperature as measured by infrared thermography.
(H) Representative infrared pictures of iBAT of WT and TRb KO mice.
(I) Representative H&E stainings of ingWAT and iBAT of WT and TRb KO mice. Scale bar 10 mm.
(J and K) Gene expression analysis of (J) ingWAT and (K) iBAT of WT and TRb KO mice.
Data are presented as mean ± SEM; n = 5. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S2.UCP1 (Shabalina et al., 2010). Interestingly, expression of genes
involved in lipogenesis and lipolysis (peroxisome proliferator-
activated receptor gamma [Pparg]; fatty acid translocase [Cd36];
carbohydrate-responsive element-binding protein beta [Chrebpb];
lipoprotein lipase [Lpl]; leptin [Lep]; lipase A [Lipa]; stearoyl-coen-
zyme A [CoA] desaturase 1 [Scd1]; fatty acid synthase [Fasn])
wasmostly unaltered in ingWAT (Figure S2I) while being reduced
in iBAT of hyperthyroid mice (Figure S2J). Collectively, these
data suggest that, despite a molecular browning fingerprint
including elevated UCP1 protein, the metabolic turnover is not
elevated in thermogenic adipose tissues of hyperthyroid animals.
Thyroid-Hormone-Induced Hyperthermia Is
Independent of SNS Signaling in Adipose Tissues
T3 centrally activates thermogenesis via the SNS (Alvarez-
Crespo et al., 2016; Lo´pez et al., 2010; Martı´nez-Sa´nchezet al., 2017b). Interestingly, we observed a downregulation of
Adrb3 expression in iBAT and ingWAT in systemic hyperthyroid-
ism, suggesting reduced adrenergic responsiveness of these
tissues. We then measured NE turnover in hyperthyroid mice
(Figures S3A and S3B). The data revealed that baseline NE levels
(0 h) and NE turnover were not significantly different between
controls and T3- or T4-treated mice at room temperature in in-
gWAT but lower in iBAT (Figures 4A, 4B, S3C, and S3D). This
was accompanied by normal levels of tyrosine hydroxylase
protein in both tissues (Figures S3E–S3G) and suggests that
the elevation of body temperature in systemically hyperthyroid
animals might not be caused by a central activation of the
SNS. To elucidate this in greater detail, we housed mice at ther-
moneutrality (TN) (Figure 4C), where thermogenic adipose tissue
is only minimally innervated due to the lack of facultative thermo-
genesis (Cannon and Nedergaard, 2004; Sjo¨gren et al., 2007).Cell Reports 27, 3385–3400, June 11, 2019 3389
Figure 3. Hyperthyroidism Decreases Adipose Tissue Glucose and Lipid Uptake
(A) Rate of glucose metabolism in ingWAT of control and hyperthyroid mice after 14 days of treatment as measured by 18FDG-PET/CT. n = 7–14.
(B) Representative 18FDG-PET/CT pictures of ingWAT of control and hyperthyroid mice. White arrows indicate ingWAT depot analyzed.
(C) Rate of glucose metabolism in iBAT of control and hyperthyroid mice after 14 days of treatment as measured by 18FDG-PET/CT. n = 7–14.
(D) Representative 18FDG-PET/CT pictures of iBAT of control and hyperthyroid mice. White arrows indicate iBAT depot analyzed.
(E) Uptake of radioactively labeled TRLs into ingWAT and iBAT of control and T3- and T4-treated mice after 14 days of treatment. n = 7–8.
(legend continued on next page)
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Interestingly, TN-housed mice still displayed a significantly
elevated body temperature already after 1 day of treatment
with T3 (Figures 4D, 4E, S3H, and S3I). As expected, NE levels
in ingWAT (Figures 4F and S3J) as well as iBAT (Figures 4G
and S3K) were strongly reduced at TN as compared to room
temperature. Only when normalized to tissue weight, but not
protein content, T3 caused a significantly further decline of NE
in iBAT at both temperatures (Figures 4G and S3K). In both tis-
sues, no significant change was observed in intracellular cAMP
(Figures 4H and 4I) and free fatty acids (Figures 4J and 4K). Inter-
estingly, ingWAT of T3-treated mice at TN still showed histolog-
ical signs of browning (Figure 4L), together with increased
expression of Ucp1, albeit at much lower levels (Figure 4M;
Table S1). As expected, we found ‘‘whitened iBAT’’ in control
and T3-treated mice at TN characterized by bigger, unilocular
cells (Figure 4L). The lowerUcp1 gene expression in iBAT by sys-
temic T3 treatment was reversed at TN (Figure 4N; Table S1),
which together with elevated UCP1 protein (Figure 4O) suggests
a ‘‘re-browning’’ of the whitened iBAT by T3. Together, our data
implicate that the increase in body temperature and the brown-
ing of ingWAT in systemic hyperthyroidism occur independently
of SNS activation. Moreover, the beige fat seems to lack thermo-
genic activity due to insufficient sympathetic stimulation.
Interestingly, this is opposite to what is observed in central hy-
perthyroidism, which is characterized by marked SNS activation
(Lo´pez et al., 2010; Martı´nez-Sa´nchez et al., 2017b). We there-
fore tested whether the AMPK pathway in the ventromedial nu-
cleus of the hypothalamus (VMH) is triggered by the systemic
T3 treatment. Our data revealed that there was no effect of the
systemic T3 treatment at 23C or 30C on AMPKa phosphoryla-
tion in the VMH (Figures 4P–4S), despite T3 reaching the brain as
evidenced by the T3-induced hypothalamic genes Dio3, Hr, and
Klf9 (Figure S3L), as well as significantly increased hypothalamic
T3 content (Figure S3M).
Thyroid-Hormone-Mediated Increase in Body
Temperature Persists in the Cold
To test whether alleviating the heat stress of the T3 treatment
normalizes body temperature regulation, we repeated the treat-
ment at 10C (Figures 5A, S3N, and S3O). Interestingly, the
elevation of body temperature by T3 persisted in these animals
(Figure 5B) with normal iBAT (Figures 5C and 5D) and tail temper-
ature (Figure 5E), indicating the absence of hyperthermia and a
centrally elevated body temperature setpoint. Interestingly, T3
still induced browning of ingWAT at the histological level, and
iBAT contained more fat droplets, comparable to the situation
at higher temperatures (Figure 5F). However, on the molecular
level (Figures 5G and S3P), Ucp1 mRNA was not significantly
higher in the T3-treated group, most likely because the ingWAT(F) Change in oxygen consumption of control and T3-treated mice housed at 23
(G) cAMP levels in ingWAT of mice housed and treated at 23C. n = 4.
(H) cAMP levels in iBAT of mice housed and treated at 23C. n = 4.
(I) Protein expression of HSL and phospho HSL (pHSL) in ingWAT of mice house
(J) Protein expression of HSL and pHSL in iBAT of mice housed and treated at 2
(K) Free fatty acids in ingWAT of mice housed and treated at 23C. n = 4.
(L) Free fatty acids in iBAT of mice housed and treated at 23C. n = 4.
Data are presented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. See alsoof control animals was browned by the lower temperature.
Only Dio2 mRNA levels were still elevated by the T3 treatment
(Figure 5G). In contrast, iBAT showed lower expression of ther-
mogenic genes and Adrb3 in the T3 group (Figures 5H and
S3Q), with normal UCP1 protein (Figure 5I). The NE stimulation
test showed a stronger response in both groups and a smaller
difference between T3-treated and untreated animals (Figure 5J),
suggesting a lower additional effect of T3 on thermogenic capac-
ity at 10C as compared to 23C. We observed comparable
levels of NE and intracellular cAMP in ingWAT and iBAT of
both groups (Figures 5K–5N, S3R, and S3S). Interestingly, free
fatty acids were significantly elevated in ingWAT of T3-treated
mice, and no difference was found in iBAT (Figures 5O and
5P). When we analyzed the VMH, we observed that now, in the
absence of heat stress as evidenced by the normal tail temper-
ature, AMPKa phosphorylation was reduced by the T3 treatment
(Figures 5Q and 5R).
Thyroid-Hormone-Mediated Increase in Body
Temperature Is Independent of UCP1
As neither beige nor brown fat appeared to be active in hyperthy-
roid mice at room temperature, we hypothesized that the
observed hyperthermia might not depend on UCP1-mediated
thermogenesis. To test this directly, we treated UCP1 KO mice
and their WT littermates at room temperature with T3 (Figure 6A),
resulting in both genotypes in a decrease in serum tT4 and a
strong increase in serum tT3 (Figures S4A and S4B) and reduced
blood glucose levels in the ipGTT (Figures 6B and 6C; ipGTT: pge-
notype = 0.466, pT3 < 0.0006, and pinteraction = 0.892). The relative
amount of lean mass was increased in T3-treated WT and UCP1
KO mice, and the relative amount of fat mass was not signifi-
cantly altered (Figures S4C and S4D; lean mass: pgenotype =
0.721, pT3 < 0.0008, and pinteraction = 0.065; fat mass: pgenotype =
0.458, pT3 = 0.565, and pinteraction = 0.069). Body temperature
was significantly elevated in both groups after treatment with
T3 (Figure 6D; body temperature: pgenotype = 0.794, pT3 <
0.0001, and pinteraction = 0.213). Interestingly, we found multiloc-
ular cells in ingWAT of UCP1 KOmice after T3 treatment as a his-
tological sign of browning, and the multilocular cells in the iBAT
of these mice appeared bigger (Figure 6E). Moreover, we found
an increased expression of Cidea after T3 treatment in UCP1 KO
mice, and most other markers of browning were not altered in
ingWAT (Figure 6F; Table S2). iBAT gene expression of WT
and UCP1 KO mice showed a decrease in Adrb3, Dio2, and
Ppargc1a in systemic hyperthyroidism (Figure 6G; Table S2). It
was reported that ingWAT features other thermogenic mecha-
nisms, like calcium or creatine cycling (Ikeda et al., 2017; Kazak
et al., 2015, 2017); however, we only found a minor increase in
Serca2 (Atp2a2) gene expression in ingWAT of T3-treated WTC after NE injection. n = 6.
d and treated at 23C. n = 4.
3C. n = 4.
Figure S2.
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Figure 4. Thyroid-Hormone-Induced Hyperthermia Is Independent of SNS Signaling
(A and B) NE turnover in (A) ingWAT and (B) iBAT of control and T3- and T4-treatedmice after 14 days of treatment normalized against tissue weight. n = 4 per time
point and group.
(legend continued on next page)
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andUCP1 KOmice, andmarkers of creatinemetabolism (glycine
amidinotransferase [Gatm]; guanidinoacetate N-methyltransfer-
ase [Gamt]; mitochondrial creatine kinase 1 and 2 [Ckmt1 and
Ckmt2]; creatine transporter 1 or solute carrier family 6 member
8 [Slc6a8]; phosphoethanolamine/phosphocholine phosphatase
[Phospho1]) were unchanged in ingWAT or iBAT (Figures S4E
and S4F; Table S2).
Given these results, we hypothesized that the muscle as the
other main thermogenic tissue could be responsible for the hy-
perthermia. This was supported by an elevated restingmetabolic
rate (fasted and measured at 30C) in T3-treated WT mice (Fig-
ure 6H), an increased TRL uptake in M. Soleus (Figure 6I), a
mainly lipolytic muscle type as evidenced by normal glucose up-
take (Figure S2H). Intramuscular glycogen was decreased in M.
Gastrocnemius (Figure 6J) in the presence of mildly elevated PK
enzyme activity (Figure S4G), as expected from a hyperthyroid
muscle (Salvatore et al., 2014). On the molecular level, this was
accompanied by an alteration of several genes involved in regu-
lating energy expenditure in both muscle types, including the
uncoupling protein Ucp3, the mitochondrial shuttle Gpd2, or
genes connected to calcium handling (uncoupling protein 3
[Ucp3]; glycerol-3-phosphate dehydrogenase 2 [Gpd2]; peroxi-
some proliferator activated receptor delta [Ppard]; sarcolipin
[Sln]; ryanodine receptor 1 [Ryr1]; ATPase Na+/K+ transporting
subunit alpha 2 [Atp1a2]; glucose transporter 1 [Slc2a1, Glut1];
glucose transporter 4 [Slc2a4, Glut4]; lactate dehydrogenase a
[Ldha]; Figures 6K, 6L, S4H, and S4I). Likewise, we observed
increased SERCA2 protein in M. Soleus, together with an
induced expression of mitochondrial respiratory complex pro-
teins (Figures 6M–6O). Taken together, these findings show
that the metabolic effects of T3 contributing to the hyperthermia
at 23C are caused by skeletal muscle rather than thermogenic
adipose tissue.
DISCUSSION
Thyroid hormones are essential components in the regulation of
metabolism (Lo´pez et al., 2013; Mullur et al., 2014; Silva, 2006;
Warner and Mittag, 2012; Yen, 2001). Although it is well known
that hyperthyroidism increases body temperature, the mecha-
nism remains controversial. The classic paradigm states that hy-(C) Schematic representation of housing and treatment regimen of WT mice at th
(D) Rectal temperature of control and T3-treated mice over 14 days of treatment
(E) Rectal temperature at day 14 of treatment at thermoneutrality. n = 5.
(F and G) NE content of (F) ingWAT and (G) iBAT of control and T3-treated mice
(H) cAMP levels in ingWAT of mice housed and treated at 30C. n = 5.
(I) cAMP levels in iBAT of mice housed and treated at 30C. n = 5.
(J) Quantification of free fatty acids in ingWAT of mice housed and treated at 30
(K) Quantification of free fatty acids in iBAT of mice housed and treated at 30C.
(L) Representative H&E stainings of control and T3-treated ingWAT and iBAT. M
(M and N) Gene expression analysis in (M) ingWAT and (N) iBAT of control and T
(O) UCP1 protein levels in iBAT of control and T3-treated mice housed and treat
(P) Quantification of pAMPKa in the VMH of mice housed and treated with T3 at
(Q) Representative western blot of pAMPKa expression in the ventromedial hypo
(R) Quantification of pAMPKa in the VMH of mice housed and treated with T3 at
(S) Representative western blot of pAMPKa expression in the VMH of mice hous
Data are presented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; xp
$$$$pT3 < 0.0001. See also Figure S3.perthyroidism leads to an increase in basal metabolic rate and
obligatory thermogenesis, presumably through actions in skel-
etal muscle (Santhanam et al., 2018; Silva, 2006). This simple
concept was challenged recently by studies showing that central
T3 can directly activate BAT thermogenesis via hypothalamic
AMPK signaling (Alvarez-Crespo et al., 2016; Lo´pez et al.,
2010; Martı´nez-Sa´nchez et al., 2017b) and that the hormone as
well as the TRb agonist GC-1 cause browning (Lin et al., 2015;
Weiner et al., 2016). Moreover, thyroid hormones also play an
important role in the regulation of heat dissipation over the tail
surface (Warner et al., 2013). Together, these studies demon-
strated that the regulation of body temperature by thyroid hor-
mone might be multi-layered and more complex than previously
thought. Our study now clarifies the individual contributions of
these different pathways to whole body thermoregulation in sys-
temic hyperthyroidism.
In ingWAT, we found a strong induction of browning in hyper-
thyroidism, with UCP1 reaching levels comparable to about one-
third of those found in iBAT. This required TRb, as browning was
absent in hyperthyroid TRbKOmice. The precisemechanism re-
mains yet to be elucidated but could be mediated by a direct
activation of the browning program in white adipose tissue, as
T3 is known to directly induce the expression of Ucp1 in iBAT
(Rabelo et al., 1995; Silva, 2006) or by the induction of Fgf21
expression in liver (not shown), which can also induce browning
(Finan et al., 2016; Fisher et al., 2012; Hotta et al., 2009; Inagaki
et al., 2007; Kharitonenkov et al., 2005). Further studies employ-
ing a tool to obtain a precise browning fingerprint (Cheng et al.,
2018) may shed light on the underlying mechanism.
In line with the direct effect of T3 on peripheral TRb, the brown-
ing by thyroid hormone seems to be independent of the SNS, as
neither NE nor cAMP content in hyperthyroid ingWAT were
elevated, and it was still observed at thermoneutrality, where ad-
ipose tissue is functionally denervated (Cannon andNedergaard,
2004). Surprisingly, 18FDG-PET/CT and TRL uptake studies
demonstrated that the beige adipose tissue induced by T3 is
neither metabolically nor thermogenically active and might not
contribute to the hyperthermia despite high UCP1. This was
further supported in iBAT by increased lipid deposition and
elevated leptin expression indicative of a switch to a more
white-fat-like phenotype (Frederich et al., 1995), decreasedermoneutrality.
at thermoneutrality. n = 5.
at 23C and 30C. n = 4–5.
C. n = 5.
n = 5.
ice were housed and treated at thermoneutrality. Scale bar 10 mm.
3-treated mice housed and treated at 23C or 30C, respectively. n = 5–8.
ed at 30C.
23C. n = 4.
thalamus (VMH) of mice housed and treated with T3 at 23C.
30C. n = 3–5.
ed and treated with T3 at 30C.
Interaction < 0.05;
#pambient temperature < 0.05;
####pambient temperature < 0.0001;
Cell Reports 27, 3385–3400, June 11, 2019 3393
Figure 5. Thyroid-Hormone-Mediated Increase in Body Temperature Persists in the Cold
(A) Scheme of treatment regimen for induction of hyperthyroidism in WT mice at 23C, following treatment at 10C.
(B) Rectal temperature of control and T3-treated mice at the end of treatment at 10C.
(legend continued on next page)
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glucose and lipid uptake, as well as reduced iBAT surface tem-
perature, both in absolute values as well as when normalized to
body temperature—a mathematical way to compensate for the
elevated temperature of the blood circulating through the BAT.
These findings of reducedmetabolic activity in thermogenic fat
are at first glance counterintuitive, as central hyperthyroidism in
rats leads to iBAT activation through the SNS triggered by
reduced AMPKa phosphorylation in the VMH (Alvarez-Crespo
et al., 2016; Lo´pez et al., 2010; Martı´nez-Sa´nchez et al., 2017b).
However, when mice were treated with systemic T3 at 23C
and 30C, no effect on AMPKa phosphorylation in the VMH
was found, suggesting that the central T3 activation of iBAT ther-
mogenesis may be blocked by an upstream thermostat. This
seems plausible, as additional facultative thermogenesis is not
required in the T3-treated mice at 23C, because an excess of
heat is already being produced and dissipated by the tail. Conse-
quently, reduced AMPKa phosphorylation was only detected
when the mice were exposed to cold during the T3 treatment,
although the amount of hypothalamic T3 was comparable at
10C, 23C, or 30C (not shown). Importantly, at 10C the periph-
eral heat production is fully used to contribute to themaintenance
of body temperature and does not cause hyperthermia as indi-
cated by normal tail temperature. Therefore, the upstream block
of the VMH seems to be released, allowing the expected central
effect of T3 on the VMH. Most interestingly, cold-exposed
T3-treated mice still had a higher body temperature, demon-
strating that thyroid hormone also elevates the centrally defended
body temperature. This suggests the coexistence of hyperther-
mia and pyrexia in T3-treatedmice,with the hyperthermia prevail-
ing at room temperature and above and the pyrexic phenotype
appearing in the cold. It is now tempting to speculate that this
simultaneous hyperthermic and pyrexic effect of thyroid hormone
could have been an important factor in the evolutionary develop-
ment of endothermy (Little and Seebacher, 2014).
The concept may also explain why ingWAT and iBAT are not
activated despite their high UCP1 protein content in T3-treated
mice: at 23C and 30C, the peripheral hyperthermia seems to
be more than sufficient to maintain body temperature even at
the elevated setpoint, and further facultative thermogenesis
would not be beneficial. The apparent discrepancy between
high UCP1 and not elevated thermogenesis concurs with previ-
ous findings, demonstrating that the mere presence of UCP1 is
not sufficient for thermogenesis (Shabalina et al., 2010), and
additional stimulation of the protein by free fatty acids is required
to exploit the full thermogenic potential. In the T3-treated tissues,(C) iBAT temperature as measured by infrared thermography at the end of treatm
(D) Representative infrared (IR) pictures of control and T3-treated mice at the en
(E) Tail temperature of control and T3-treated mice at the end of treatment at 10
(F) Representative H&E stainings of ingWAT and iBAT of WT mice housed and tr
(G and H) Gene expression in (G) ingWAT and (H) iBAT of control and T3-treated
(I) UCP1 protein levels in iBAT of control and T3-treated mice housed and treate
(J) Change in oxygen consumption of control and T3-treated mice housed at 10
(K and L) NE content in (K) ingWAT and (L) iBAT of control and T3-treated mice a
(M and N) cAMP levels in (M) ingWAT and (N) iBAT of mice housed and treated a
(O and P) Quantification of free fatty acids in (O) ingWAT and (P) iBAT of mice ho
(Q) Quantification of pAMPKa in the VMH of mice housed and treated with T3 at
(R) Representative western blot of pAMPKa expression in the VMH of mice hous
Data are presented as mean ± SEM; n = 6. *p < 0.05; **p < 0.01; ***p < 0.001. Sewe did not detect such an increase in free fatty acids. Although
SNS activity has not been measured directly, the lack of induc-
tion in intracellular cAMP suggests insufficient adrenergic stimu-
lation, which may be partially explained by the reduced expres-
sion of Adrb3 by T3 (Rubio et al., 1995; Silva, 2006). That the
available UCP1 can be activated has been demonstrated by
the NE stimulation of the T3-treated animals, which unleashed
a strong increase in energy expenditure. It should be noted
thatUcp1mRNA levels can be disconcordant with protein levels,
presumably due to the relatively long half-life of the UCP1 protein
(Puigserver et al., 1992), which has been observed here and in
previous studies (Nedergaard and Cannon, 2013).
Our findings in UCP1 KO mice, which still display increased
body temperature upon T3, finally confirmed that the effect is
independent of brown or beige adipose tissue. Although other
thermogenic mechanisms, like calcium or creatine cycling, exist
(Ikeda et al., 2017; Kazak et al., 2015, 2017), they also do not
seem to contribute to thermogenesis, as they were not induced
on the mRNA level. This demonstrates that systemic treatment
with thyroid hormone activates thermogenic pathways in tissues
other than adipose depots (Silva, 2006). Given the elevated
restingmetabolic rate of T3-treated fastedmice at thermoneutral-
ity, which under these conditions cannot result from any UCP1-
mediated thermogenesis (Feldmann et al., 2009), as well as the
increased lipid uptake and reduced glycogen content of M.
Soleus and M. Gastrocnemius, respectively, it seems likely that
the skeletal muscle is the source of the peripheral hyperthermia.
This is supported by increased expression of genes and proteins
involved in wasting cellular energy, such as Ucp3, Gpd2, or
Serca2 (Cannon and Nedergaard, 2010). Our findings are in
concordance with previous studies, showing increased glucose
turnover in skeletal muscle of hyperthyroid humans (Gavrila
et al., 2017) and elevated fatty acid uptake in skeletal muscle of
hyperthyroid rats (Klieverik et al., 2009). As muscle is predomi-
nantly TRa1 tissue, this would explain why a similar hyperthermia
is not observed in mice treated with GC-1 (Lin et al., 2015).
In conclusion, our data demonstrate a strong and direct induc-
tion of browning of ingWAT in systemic hyperthyroidism in
a TRb-dependent manner. Although all classical features of
browning, including the change in morphology and the increase
in UCP1, are present, the beige fat does not contribute to whole-
body metabolism or thermogenesis (Kalinovich et al., 2017;
Nedergaard and Cannon, 2013; Shabalina et al., 2013). This is
caused by the concomitant increase in basal metabolic rate
mediated by TRa1 in muscle, which provides more heat thanent normalized to rectal temperature.
d of treatment at 10C.
C.
eated with T3 at 10C. Scale bar 10 mm.
mice at 10C.
d at 10C.
C after NE injection.
t 10C.
t 10C.
used and treated at 10C.
10C.
ed and treated with T3 at 10C.
e also Figure S3.
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required to meet the simultaneously elevated setpoint, and
consequently blocks further sympathetic activation by central
mechanisms. Our findings thus demonstrate that the metabolic
and thermogenic consequences of systemic hyperthyroidism
do not rely on browning and that the mere presence of beige
fat with detectable levels of UCP1 protein and other histological
and molecular markers of browning does not necessarily trans-
late to a metabolically active tissue. Therefore, a combination
of techniques, including glucose and lipid turnover, as well as
UCP1 KO mice should always be applied to validate the true
thermogenic potential of the multiple other stimuli reported to
induce browning (Castro et al., 2017; Tamucci et al., 2018; Var-
gas-Castillo et al., 2017; Warner and Mittag, 2016).
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Unless stated otherwise, animals were housed in groups at 23 ± 1C at constant 12 hour light/dark cycle with ad libitum access to food
and water. Experiments were conducted in male mice at the age of three to six months. Wild-type C57/BL6NCr (RRID:MGI:2160593)
were purchased fromCharles River Laboratories (Charles River, Germany), TRb komice (RRID:IMSR_JAX:003462), UCP1 komice and
Per1/Per2 dko mice were generated as described before (Enerba¨ck et al., 1997; Forrest et al., 1996; Husse et al., 2012) and knockout
mice were always compared to WT littermate controls. All animal procedures were approved by the MELUR Schleswig-Holstein,
LANUV Nordrhein-Westfalen and the BGV Hamburg, Germany.
METHOD DETAILS
Study design
Hyperthyroidismwas induced by treatment with THs in drinking water as recommended by the American Thyroid Association guide-
lines with a dose low enough to avoid cachexia (Bianco et al., 2014), i.e., 1 mg/L L-Thyroxine (T2376, Sigma Aldrich, Germany) in
0.01% BSA (A7906, Sigma Aldrich, Germany) or 0.5 mg/L 3,30,5-Triiodo-L-thyronine (T6397, Sigma Aldrich, Germany) in 0.01%
BSA for 14 days (Figure 1A). Control mice received 0.01%BSA. Basic metabolic profiling was performed by measuring body weight,
food and water intake, measurement of core body temperature using a rectal probe (BAT-12, Physitemp, USA), infrared thermog-
raphy (T335, FLIR, Sweden) (Warner et al., 2013), and glucose tolerance tests (ipGTT, 2 g/kg body weight). Body composition
wasmeasured usingMinispec LF110 andMinispec Plus Software 6.0 (Bruker Corp., Billerica, MA, USA). Organ collectionwas always
performed in the middle of the light phase, unless stated otherwise.
PET-CT
[18F]-FDG PET imaging and kinetic modeling was performed as described before (Jais et al., 2016). For the analysis of the parametric
images of the metabolic rate of glucose (MRglc) volumes of interests (VOIs) containing iBAT or ingWAT, respectively were defined for
each individual animal and each measurement.
TRL Uptake
Uptake of triglyceride-rich lipoproteins and [3H]2-Deoxyglucose (3HDG) in hyperthyroid C57/BL6NCr mice was investigated as
described before (Bartelt et al., 2011). Briefly, mice were fasted for 4 hr before receiving an intravenous injection of 100 mL radiola-
belled recombinant TRLs (80 mg triglycerides/kg) labeled with 14C-triolein (0.6 MBq/kg) and 3HDG. Organs from anesthetized mice
were harvested after systemic perfusion with PBS-heparin (10 U/ml) via the left heart ventricle. Tissues were homogenized using
Solvable (Perkin Elmer) and radioactivity was determined using liquid scintillation counting.
Indirect Calorimetry and nonshivering thermogenic capacity
Measurements of daily energy expenditure and basal metabolic rate in WT and TRb ko littermates was performed in single-housed
animals using Phenomaster (TSE Systems, Germany). Oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory
exchange rate (RQ), and energy expenditure (EE) were calculated with Microsoft Office Excel and Phenomaster software (TSE
Systems, Germany). Basal metabolic rate was measured for 1 hour in animals fasted for 6 hours at 30C.
Energy expenditure, respiratory exchange rate and nonshivering thermogenic capacity in fasted control and T3-treated mice were
performed using theCaloBox system (PhenoSysGmbH,Germany). Formeasurement of daily energy expenditure at 23Cand resting
metabolic rate at 30C, mice were acclimated to the chambers individually for at least 60 minutes, before basal O2 consumption and
CO2 production was analyzed for up to 60 minutes in 20 s intervals. For analysis of nonshivering thermogenesis capacity in mice
housed and treated at 10C or 23C, respectively, mice were acclimated to chambers for at least 60 minutes. Then basal energy
expenditure at 23C was measured for 30 minutes, before injecting mice subcutaneously with 1 mg/kg NE (Arterenol, Sanofi) and
measuring O2 consumption and CO2 production in intervals of 20 s for at least 60 minutes after injection. The change in oxygen con-
sumption (DVO2) was calculated by subtracting basal O2 consumption before NE injection from O2 consumption after NE injection.
NE turnover
In order to determine NE turnover in hyperthyroid WT mice, n = 16 mice per group were treated for two weeks with T3 or T4, respec-
tively. On the last day of treatment mice were injected with the tyrosine hydroxylase inhibitor a-methyl-DL-tyrosine methyl ester
hydrochloride (i.p. 120 mg/kg) (AMPT, M3281, Sigma Aldrich, Germany) and sacrificed after 0, 2, 4 and 6 hours (n = 4 per group
and time point), respectively. Catecholamines were extracted in 2% perchloric acid (PCA, 48%–50%, 44464, Alfa Aesar, MA,
USA) and quantified as described before (Dalley et al., 2002). Protein content of the samples was quantified using DC Protein Assay
Kit according to manufacturer’s protocol (Bio-Rad Laboratories, Inc.).
Gene expression analysis
For gene expression analysis, RNA was isolated using QIAGEN RNeasy Kits (QIAGEN, Germany), transcribed into cDNA (Molecular
Biology RevertAid Strand cDNA Kit, Thermo Fisher Scientific, Germany) following manufacturer’s instructions. qPCR analysis wase2 Cell Reports 27, 3385–3400.e1–e3, June 11, 2019
performed using SYBR Green PCR Master Mix (Roche, Germany) and QuantStudio Applied Biosystems (Thermo Fisher Scientific,
Germany). Efficiency of the PCR was calculated using standard curves and levels of gene expression were normalized to a house-
keeping gene (ribosomal protein lateral stalk subunit P0, Rplp0 and peptidylprolyl isomerase a, Ppia for adipose tissues; Ppia and
hypoxanthine phosphoribosyltransferase, Hprt for M. Soleus and M.Gastrocnemius, and Hprt for pituitary and hypothalamus) using
the DDCT method. Primer sequences are listed in Table S3.
Western Blot
Protein isolation from snap-frozen tissue was performed by homogenizing tissues in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH
7.5, 0.1% wt/vol SDS, 0.5% wt/vol sodium deoxycholate, 1% vol/vol Nonidet P40, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium
pyrophosphate, 1 mMNaVO4 and 10mMNaF), with freshly added Protease inhibitors (5892970001, Roche Diagnostics GmbH, Ger-
many). Protein concentration was determined using Pierce BCA Kit (23227, Thermo Scientific, Germany). Electrophoresis was per-
formed using SDSGels (TGX Stain Free FastCast Acrylamide Kit (1610183, 1610185, Bio-Rad Laboratories, Germany). Proteins were
then transferred onto PVDF membrane (IPVH00010, Merck Millipore, Ltd, Cork, Ireland), blocked for 1 hour in 5%milk in TBS-T and
incubated with primary antibodies (anti-UCP1; Jastroch et al., 2012); anti-Serca2, 4388, Cell Signaling Technology, Inc.; anti-HSL,
4107, Cell Signaling Technology, Inc.; anti-pHSL(Ser660), 4126S, Cell Signaling Technology, Inc.; anti-OxPhos cocktail, 45-8099,
Invitrogen; anti-Tyrosine Hydroxylase, C2928, Sigma; anti-b-actin, A1978, Sigma; anti-HSP90, 4877, Cell Signaling Technology,
Inc.) for 16 hours at 4C. Afterward membranes were washed 4x10 minutes, incubated with secondary antibodies (anti-rabbit poly-
clonal HRP-conjugated antibody, P0448, DAKO, Denmark; anti-mouse polyclonal HRP-conjugated antibody, P0447, DAKO,
Denmark) for 1 hour at room temperature, and washed again for 4x10 minutes. Chemiluminescence was recorded using Advansta
WesternBright Quantum (K-12041-D20, Advansta, USA) and ChemiDoc Touch Imaging System (Bio-Rad Laboratories, Germany).
Quantification of band intensities was performed using ImageLabTM Software (Bio-Rad Laboratories, Germany). Protein expression
analysis in the VMH (anti-pAMPKa(Thr172), 2535, Cell Signaling Technology, Inc.; anti-b-actin(AC-74), A5316, Sigma) was performed
as described before (Alvarez-Crespo et al., 2016). Protein expression was normalized to total protein content transferred onto the
membrane, or housekeeping proteins, respectively.
Enzyme activity and glycogen measurement
Glycogen content in liver and M. Gastrocnemius, as well as activities of Pyruvate Kinase and hepatic Phosphoenolpyruvate
Carboxykinase of snap-frozen tissue were determined as described before (Vujovic et al., 2009).
ELISA
Serum levels of tT4 (EIA-1781, DRG Diagnostics, Germany) and tT3 (DNOV053, NovaTec Immundiagnostica GmbH, Germany) were
determined according to manufacturer’s instructions. Hypothalamic T3 content was measured in pooled hypothalamic punches of
the lateral and basal hypothalamus as described previously (Zhang et al., 2016). cAMP levels in ingWAT and iBAT were determined
according to manufacturer’s instructions (RPN225, GE Healthcare, UK). Free fatty acids in ingWAT and iBAT samples were analyzed
according to manufacturer’s instructions (ab65341, abcam plc; UK).
Histology
Tissues were fixed in 4% paraformaldehyde for 48 hours, dehydrated by washing in increasing concentrations of ethanol and xylol
before embedding into paraffin. Tissues were cut in 5 mm slides and stained with Hemalun and Eosin according to themanufacturer’s
protocol (X883.2, T865.3, Carl Roth GmbH&Co KG, Germany).
QUANTIFICATION AND STATISTICAL ANALYSIS
For analysis of all data Microsoft Office Excel and GraphPad Prism 7 software was used. Analysis of circadian rhythms was per-
formed using CircWave v.1.4 software (Oster et al., 2006). The variances between groups investigated were similar and appropriate
tests were performed to analyze differences between the respective groups. For experiments with repeated-measurements a RM
ANOVA was performed with individual post-tests, the experiments of the UCP1 ko mice and T3 treatment were analyzed using a
2-WAY ANOVA with post-tests. All values are represented as mean ± SEM. Number of animals (n) per experiment are depicted in
each figure.Cell Reports 27, 3385–3400.e1–e3, June 11, 2019 e3
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(A) Serum total T4, T3 (B) and pituitary Tshb (C) in control and T3-treated mice at 23°C over the course of 24 hours. 
n=3 per group and timepoint. (D) Energy expenditure in mice housed and treated for 10 days at 23°C. n=6.  (E) 
Respiratory quotient (RQ) of control and T3-treated mice housed and treated for 10 days at 23°C. n=6. (F) Body weight 
gain over 14 days of treatment at 23°C. n=6-8. (G) Body length after 14 days of treatment at 23°C. n=6-8. (H) Food 
intake after 14 days of treatment at 23°C. n=2-4. (I) Infrared thermography after 14 days of treatment at 23°C. (J) 
ingWAT temperature measured by infrared thermography at the end of treatment normalized to body temperature. n=6-
8. (K) Weights of heart, M. Gastrocnemius and M. Soleus after 14 days of treatment at 23°C, normalized to body 
weight at the time of sacrifice. n=6-8. (L) Weights of liver, iBAT, ingWAT and gWAT after 14 days of treatment at 
23°C, normalized to body weight at the time of sacrifice. n=6-8. (M) Pictures of iBAT depots. (N) Quantification of 
UCP1 protein expression in iBAT at 23°C. n=4. (O+P) Protein expression of Complexes I - V of oxidative 
phosphorylation in iBAT at 23°C. n=4. (Q) Gene expression analysis of gWAT of control, T3- and T4-treated mice at 
23°C. n=6-8. (R) UCP1 Western Blot in gWAT at 23°C. (S) Ucp1 gene expression in ingWAT of WT and Per1/Per2 
dko mice. n=3. Data are presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
Figure S2, Related to Figure 2 and Figure 3 
 
(A) Serum total T4 levels of WT and TRβ ko littermates. n=5. (B) Serum total T3 levels of WT and TRβ ko littermates. 
n=5. (C) Daily energy expenditure of WT and TRβ ko mice. Grey areas indicate nighttime. n=5. (D) Daily energy 
expenditure of WT and TRβ ko mice over body weight. n=5. (E) UCP1 protein expression in iBAT of WT and TRβ ko 
mice. n=5. (F) Representative Western Blot of UCP1 in iBAT of WT and TRβ ko mice. (G) 3HDG uptake into gWAT 
of control, T3- and T4-treated mice. n=7-8. (H) 3HDG uptake into M. Soleus of control, T3- and T4-treated mice. n=7-
8. (I) Gene expression analysis in ingWAT and (J) iBAT of control, T3- and T4-treated mice at 23°C. n=6-8. Data are 
presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
 Figure S3, Related to Figure 4 and 5 
 
(A) Serum total T4 and T3 (B) levels after 14 days of treatment. n=16. (C) NE turnover in ingWAT and (D) iBAT. n=4 
per group and timepoint. (E-G) Protein expression of tyrosine hydroxylase in ingWAT and iBAT. n=4. (H) Serum total 
T4 and T3 (I) after 14 days of treatment at 30°C. n=5. (J) NE content of ingWAT and (K) iBAT at 23°C or 30°C. n=4-
5. (L) Gene expression in hypothalamus and pituitary at 23°C. n=6-8. (M) Hypothalamic T3 content in the T3 treated 
mice. n=15. (N) Serum total T4 and T3 (O) levels of mice at 10°C. n=6. (P) Gene expression in ingWAT and (Q) iBAT 
at 10°C. n=6. (R) NE levels in ingWAT and (S) iBAT at 10°C. n=6. Data are presented as mean ± SEM. *p<0.05, 
**p<0.01, ***p<0.001, ###pambient temperature<0.001, ####pambient temperature<0.0001 
Figure S4, Related to Figure 6 
 
(A) Serum total T4 or T3 (B) levels of WT control, UCP1 ko control, T3-treated WT, and T3-treated UCP1 ko mice. 
n=5-8 . (C) Lean mass of WT and UCP1 ko mice before and after treatment with T3 for 14 days. n=5-6. (D) Fat mass of 
WT and UCP1 ko mice before and after treatment with T3 for 14 days. n=5-6. (E) Gene expression analysis of ingWAT 
and (F) iBAT of WT control, UCP1 ko control, T3-treated WT, and T3-treated UCP1 ko mice. n=5-8. (G) Pyruvate 
kinase activity in M. Gastrocnemius of control and T3-treated mice at 23°C. n=6-8. (H) Gene expression analysis of 
M. Soleus and (I) M. Gastrocnemius of control and T3-treated mice at 23°C. n=6-8. Data are presented as mean ± SEM. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, $$$pT3<0.001 
 
 
Table S1: Statistical analysis of gene expression in ingWAT and iBAT of mice housed and treated with T3 at 
23°C and 30°C, Related to Figure 4 
 
Thermoneutral + T3 Sidak 
ingWAT interaction ambient temp. T3 23°C 30°C 
Ucp1 **** **** **** **** ns 
Dio2 *** **** **** **** ns 
Ppargc1α * **** ** *** ns 
Prdm16 ns **** ns * ns 
Adrb3 ns ns *** * ** 
 
Thermoneutral + T3 Sidak 
iBAT interaction ambient temp. T3 23°C 30°C 
Ucp1 *** * ns * ** 
Dio2 ** *** * *** ns 
Ppargc1α ns ns ns ns ns 
Prdm16 ** *** ** *** ns 
Adrb3 ** **** **** **** ns 
Gene expression data were analysed using 2-way ANOVA with ambient temperature and treatment as independent 
factors. A Sidak correction was applied for the comparison between groups. ns= not significant, *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001 
Table S2: Statistical analysis of gene expression in ingWAT and iBAT of UCP1 KO and WT littermates treated 
with T3, Related to Figure 6  
UCP1 KO + T3 Sidak 
ingWAT interaction genotype T3 WT UCP1 KO 
Dio2 ns ** ** * ns 
Ppargc1α ns ns ns ns ns 
Prdm16 ns ns ns ns ns 
Tmem26 ns ns ns ns ns 
Cidea ns ** ** ns * 
Adrb3 ns ns ns ns ns 
Atp2a2 ns ns *** * * 
Gatm ns * ns ns ns 
Gamt ns ** ns ns ns 
Ckmt1 ns ns ns ns ns 
Ckmt2 ns ns * ns ns 
Slc6a8 ns ns ns ns ns 
Phospho 1 ns ns ** ns ** 
 
 UCP1 KO + T3 Sidak 
iBAT interaction genotype T3 WT UCP1 KO 
Dio2 ns * *** ns ** 
Ppargc1α ns ns *** ns *** 
Adrb3 ns ns ** * * 
Atp2a2 ns * ns ns ns 
Gatm ns ns ns ns ns 
Gamt * * ns ns ns 
Ckmt1 ns ns ns ns ns 
Ckmt2 ns ns ns ns ns 
Slc6a8 ns ns ns ns ns 
Phospho1 ns * ns ns * 
Gene expression data were analysed using 2-way ANOVA with genotype and treatment as independent factors. A Sidak 
correction was applied for the comparison between groups. ns= not significant, *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001 
Table S3: Primer Sequences, Related to STAR Methods  
REAGENT or RESOURCE SOURCE IDENTIFIER 
Oligonucleotides   
Adrb3 for AGA AAC GGC TCT CTG GCT TTG IDT, Inc, Germany N/A 
Adrb3 rev TGG TTA TGG TCT GTA GTC TCG G IDT, Inc, Germany N/A 
Atp1a2 for CCA CCA CTG CGG AAA ATG G IDT, Inc, Germany N/A 
Atp1a2 rev GCC CTT AGA CAG ATC CAC TTG G IDT, Inc, Germany N/A 
Atp2a1 for TGT TTG TCC TAT TTC GGG GTG IDT, Inc, Germany N/A 
Atp2a1 rev AAT CCG CAC AAG CAG GTC TTC IDT, Inc, Germany N/A 
Atp2a2 for TCC GCT ACC TCA TCT CAT CC IDT, Inc, Germany N/A 
Atp2a2 rev CAG GTC TGG AGG ATT GAA CC IDT, Inc, Germany N/A 
Atp2a3 for CGT CGC TTC TCG GTG ACA G IDT, Inc, Germany N/A 
Atp2a3 rev AAG AGG TCC TCA AAC TGC TCC IDT, Inc, Germany N/A 
Cd36 for ATG GGC TGT GAT CGG AAC TG IDT, Inc, Germany N/A 
Cd36 rev GTC TTC CCA ATA AGC ATG TCT CC IDT, Inc, Germany N/A 
Chrebpβ for TCT GCA GAT CGC GTG GAG IDT, Inc, Germany N/A 
Chrebpβ rev CTT GTC CCG GCA TAG CAA C IDT, Inc, Germany N/A 
Cidea for TGA CAT TCA TGG GAT TGC AGA IDT, Inc, Germany N/A 
Cidea rev GGC CAG TTG TGA TGA CTA AGA IDT, Inc, Germany N/A 
Ckmt1 for TGT CTT CAA GAG TCA GAA CTG GC IDT, Inc, Germany N/A 
Ckmt1 rev AGC ATC CAC CAC AAC ACG TT IDT, Inc, Germany N/A 
Ckmt2 for ACA CCC AGT GGC TAT ACC CTG IDT, Inc, Germany N/A 
Ckmt2 rev CCG TAG GAT GCT TCA TCA CCC IDT, Inc, Germany N/A 
Dio2  for ATG GGA CTC CTC AGC GTA GAC IDT, Inc, Germany N/A 
Dio2  rev ACT CTC CGC GAG TGG ACT T IDT, Inc, Germany N/A 
Fasn for GGA GGT GGT GAT AGC CGG TAT IDT, Inc, Germany N/A 
Fasn rev TGG GTA ATC CAT AGA GCC CAG IDT, Inc, Germany N/A 
Gamt for CAC GCA CCT GCA AAT CCT G IDT, Inc, Germany N/A 
Gamt rev TAC CGA AGC CCA CTT CCA AGA IDT, Inc, Germany N/A 
Gatm for GCT TCC TCC CGA AAT TCC TGT IDT, Inc, Germany N/A 
Gatm rev CCT CTA AAG GGT CCC ATT CGT IDT, Inc, Germany N/A 
Glut1 for TCA AAC ATG GAA CCA CCG CTA IDT, Inc, Germany N/A 
Glut1 rev AAG AGG CCG ACA GAG AAG GAA IDT, Inc, Germany N/A 
Glut4 for GTG ACT GGA ACA CTG GTC CTA IDT, Inc, Germany N/A 
Glut4 rev CCA GCC ACG TTG CAT TGT AG IDT, Inc, Germany N/A 
Gpd2 for GAA GGG GAC TAT TCT TGT GGG T IDT, Inc, Germany N/A 
Gpd2 rev GGA TGT CAA ATT CGG GTG TGT IDT, Inc, Germany N/A 
Ldha for CAT TGT CAA GTA CAG TCC ACA CT IDT, Inc, Germany N/A 
Ldha rev TTC CAA TTA CTC GGT TTT TGG GA IDT, Inc, Germany N/A 
Lep for GAG ACC CCT GTG TCG GTT C IDT, Inc, Germany N/A 
Lep rev CTG CGT GTG TGA AAT GTC ATT G IDT, Inc, Germany N/A 
Lipa for AGC GAC GAC TTG GTG TTC C IDT, Inc, Germany N/A 
Lipa rev GCT GAG CAA GAC TCC ACC G IDT, Inc, Germany N/A 
Lpl for GGT TGC GCG TAG AGA GGA TG IDT, Inc, Germany N/A 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Oligonucleotides   
Lpl rev CTC ACG CTC TGA CAT GCC TTC IDT, Inc, Germany N/A 
Phospho1 for ATG AGC GGG TGT TTT CCA G IDT, Inc, Germany N/A 
Phospho1 rev ATC GAA GTC GAA GGT GAG GAG IDT, Inc, Germany N/A 
Pparδ for TCC ATC GTC AAC AAA GAC GGG IDT, Inc, Germany N/A 
Pparδ rev ACT TGG GCT CAA TGA TGT CAC IDT, Inc, Germany N/A 
Pparγ for TCG CTG ATG CAC TGC CTA TG IDT, Inc, Germany N/A 
Pparγ rev GAG AGG TCC ACA GAG CTG ATT IDT, Inc, Germany N/A 
Ppargc1α - total for TGA TGT GAA TGA CTT GGA TAC A IDT, Inc, Germany N/A 
Ppargc1α - total ref GCT CAT TGT TGT ACT GGT TGG A IDT, Inc, Germany N/A 
Ppia for GCA GTA CAG CCC CAA AAT GG IDT, Inc, Germany N/A 
Ppia rev AAC AAA GTC TGG CCT GTA TCC AA IDT, Inc, Germany N/A 
Prdm16 for CCC CAC ATT CCG CTG TGA T IDT, Inc, Germany N/A 
Prdm16 rev CTC GCA ATC CTT GCA CTC A IDT, Inc, Germany N/A 
Rplp0 for TCG GGT CCT AGA CCA GTG TTC IDT, Inc, Germany N/A 
Rplp0 rev AGA TTC GGG ATA TGC TGT TGG C IDT, Inc, Germany N/A 
Ryr1 for CAG TTT TTG CGG ACG GAT GAT IDT, Inc, Germany N/A 
Ryr1 rev CAC CGG CCT CCA CAG TAT TG IDT, Inc, Germany N/A 
Scd1 for TTC TTG CGA TAC ACT CTG GTG C IDT, Inc, Germany N/A 
Scd1 rev CGG GAT TGA ATG TTC TTG TCG T IDT, Inc, Germany N/A 
Slc6a8 for GTC TGG TGA CGA GAA GAA GGG IDT, Inc, Germany N/A 
Slc6a8 rev CCA CGC ACG ACA TGA TGA AGT IDT, Inc, Germany N/A 
Sln for GAGGTGGAGAGACTGAGGTCCTTGG IDT, Inc, Germany N/A 
Sln rev GAAGCTCGGGGCACACAGCAG IDT, Inc, Germany N/A 
Tfam for GGA ATG TGG AGC GTG CTA AAA IDT, Inc, Germany N/A 
Tfam rev TGC TGG AAA AAC ACT TCG CAA TA IDT, Inc, Germany N/A 
Tfam for GGA ATG TGG AGC GTG CTA AAA IDT, Inc, Germany N/A 
Tfam rev ACA AGA CTG ATA GAC GAG GGG IDT, Inc, Germany N/A 
Tmem26 for TTC CTG TTG CAT TCC CTG GTC IDT, Inc, Germany N/A 
Tmem26 rev GCC GGA GAA AGC CAT TTG T IDT, Inc, Germany N/A 
Ucp1 for ACT CAG GAT TGG CCT CTA CG IDT, Inc, Germany N/A 
Ucp1 rev CCA CAC CTC CAG TCA TTA AGC IDT, Inc, Germany N/A 
Ucp3 for GAG ATG GTG ACC TAC GAC ATC A IDT, Inc, Germany N/A 
Ucp3 rev GCG TTC ATG TAT CGG GTC TTT A IDT, Inc, Germany N/A 
 
 
 
